These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28536176)

  • 1. Cost of Alteplase Has More Than Doubled Over the Past Decade.
    Kleindorfer D; Broderick J; Demaerschalk B; Saver J
    Stroke; 2017 Jul; 48(7):2000-2002. PubMed ID: 28536176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2007 rates; fiscal year 2007 occupational mix adjustment to wage index; health care infrastructure improvement program; selection criteria of loan program for qualifying hospitals engaged in cancer-related health care and forgiveness of indebtedness; and exclusion of vendor purchases made under the competitive acquisition program (CAP) for outpatient drugs and biologicals under part B for the purpose of calculating the average sales price (ASP). Final rules and interim final rule with comment period.
    Centers for Medicare and Medicaid Services (CMS), HHS
    Fed Regist; 2006 Aug; 71(160):47869-8351. PubMed ID: 16921666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How diagnosis-related group 559 will change the US Medicare cost reimbursement ratio for stroke centers.
    Demaerschalk BM; Durocher DL
    Stroke; 2007 Apr; 38(4):1309-12. PubMed ID: 17332446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteplase for the treatment of acute ischaemic stroke: a single technology appraisal.
    Jones ML; Holmes M
    Health Technol Assess; 2009 Sep; 13 Suppl 2():15-21. PubMed ID: 19804685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National use of thrombolysis with alteplase for acute ischaemic stroke via telemedicine in Denmark: a model of budgetary impact and cost effectiveness.
    Ehlers L; Müskens WM; Jensen LG; Kjølby M; Andersen G
    CNS Drugs; 2008; 22(1):73-81. PubMed ID: 18072816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicare program; changes to the hospital inpatient prospective payment system for acute care hospitals and fiscal year 2010 rates; and changes to the long-term care hospital prospective payment system and rate years 2010 and 2009 rates. Final rules and interim final rule with comment period.
    Centers for Medicare and Medicaid Services (CMS), HHS
    Fed Regist; 2009 Aug; 74(165):43753-4236. PubMed ID: 19827228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute 'strokenomics': efficacy and economic analyses of alteplase for acute ischemic stroke.
    Quinn TJ; Dawson J
    Expert Rev Pharmacoecon Outcomes Res; 2009 Dec; 9(6):513-22. PubMed ID: 19941428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in MS-DRG assignment and hospital reimbursement as a result of Centers for Medicare & Medicaid changes in payment for hospital-acquired conditions: is it coding or quality?
    McNutt R; Johnson TJ; Odwazny R; Remmich Z; Skarupski K; Meurer S; Hohmann S; Harting B
    Qual Manag Health Care; 2010; 19(1):17-24. PubMed ID: 20042930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicare Program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system changes and FY2011 rates; provider agreements and supplier approvals; and hospital conditions of participation for rehabilitation and respiratory care services; Medicaid program: accreditation for providers of inpatient psychiatric services. Final rules and interim final rule with comment period.
    Centers for Medicare and Medicaid Services (CMS), HHS
    Fed Regist; 2010 Aug; 75(157):50041-681. PubMed ID: 20712087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of intravenous thrombolysis with alteplase within a 3-hour window after acute ischemic stroke.
    Ehlers L; Andersen G; Clausen LB; Bech M; Kjølby M
    Stroke; 2007 Jan; 38(1):85-9. PubMed ID: 17122430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The distributional implications of using relative prices in DRG payment systems.
    Thorpe KE
    Inquiry; 1987; 24(1):85-95. PubMed ID: 2951338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteplase for the treatment of acute ischaemic stroke: a NICE single technology appraisal; an evidence review group perspective.
    Holmes M; Davis S; Simpson E
    Pharmacoeconomics; 2015 Mar; 33(3):225-33. PubMed ID: 25424495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and fiscal year 2015 rates; quality reporting requirements for specific providers; reasonable compensation equivalents for physician services in excluded hospitals and certain teaching hospitals; provider administrative appeals and judicial review; enforcement provisions for organ transplant centers; and electronic health record (EHR) incentive program. Final rule.
    Centers for Medicare and Medicaid Services (CMS), HHS
    Fed Regist; 2014 Aug; 79(163):49853-50536. PubMed ID: 25167590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicare program; prospective payments for Medicare inpatient hospital services--HCFA. Interim final rule with comment period.
    Fed Regist; 1983 Sep; 48(171):39752-890. PubMed ID: 10310166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2006 rates. Final rule.
    Centers for Medicare and Medicaid Services (CMS), HHS
    Fed Regist; 2005 Aug; 70(155):47277-707. PubMed ID: 16097095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Diagnosis Related Groups for Inpatient Admissions and Associated Changes in Payment From 2012 to 2016.
    Gluckman TJ; Spinelli KJ; Wang M; Yazdani A; Grunkemeier G; Bradley SM; Wasfy JH; Goyal A; Oseran A; Joynt Maddox KE
    JAMA Netw Open; 2020 Dec; 3(12):e2028470. PubMed ID: 33284340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicare program; changes to the hospital inpatient prospective payment systems and rates and costs of graduate medical education: fiscal year 2002 rates; provisions of the Balanced Budget Refinement Act of 1999; and provisions of the Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000. Final rules.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2001 Aug; 66(148):39827-40102. PubMed ID: 11732554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of recombinant tissue-type plasminogen activator within 3 hours of acute ischemic stroke: current evidence.
    Boudreau DM; Guzauskas GF; Chen E; Lalla D; Tayama D; Fagan SC; Veenstra DL
    Stroke; 2014 Oct; 45(10):3032-9. PubMed ID: 25190439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of classification and payment system of in patient hospital admissions in the United States: introduction of Medicare Severity Diagnosis-Related Groups (MS-DRGs) and the Present On Admission (POA) indicator].
    Maurici M; Rosati E
    Ig Sanita Pubbl; 2007; 63(6):691-701. PubMed ID: 18216884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke: experience from Australian stroke center.
    Tan Tanny SP; Busija L; Liew D; Teo S; Davis SM; Yan B
    Stroke; 2013 Aug; 44(8):2269-74. PubMed ID: 23780955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.